177 related articles for article (PubMed ID: 20971924)
1. IL-13Rα2 has a protective role in a mouse model of cutaneous inflammation.
Sivaprasad U; Warrier MR; Gibson AM; Chen W; Tabata Y; Bass SA; Rothenberg ME; Khurana Hershey GK
J Immunol; 2010 Dec; 185(11):6802-8. PubMed ID: 20971924
[TBL] [Abstract][Full Text] [Related]
2. Scratching Counteracts IL-13 Signaling by Upregulating the Decoy Receptor IL-13Rα2 in Keratinocytes.
Ulzii D; Kido-Nakahara M; Nakahara T; Tsuji G; Furue K; Hashimoto-Hachiya A; Furue M
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284553
[TBL] [Abstract][Full Text] [Related]
3. Innate immune regulates cutaneous sensory IL-13 receptor alpha 2 to promote atopic dermatitis.
Xiao S; Lu Z; Steinhoff M; Li Y; Buhl T; Fischer M; Chen W; Cheng W; Zhu R; Yan X; Yang H; Liu Y; Dou Y; Wang W; Wang J; Meng J
Brain Behav Immun; 2021 Nov; 98():28-39. PubMed ID: 34391816
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of interleukin-13 receptor alpha1 on human keratinocytes in the skin of psoriasis and atopic dermatitis.
Wongpiyabovorn J; Suto H; Ushio H; Izuhara K; Mitsuishi K; Ikeda S; Nakao A; Okumura K; Ogawa H
J Dermatol Sci; 2003 Oct; 33(1):31-40. PubMed ID: 14527737
[TBL] [Abstract][Full Text] [Related]
5. EGFR signaling blunts allergen-induced IL-6 production and Th17 responses in the skin and attenuates development and relapse of atopic dermatitis.
Zhang Z; Xiao C; Gibson AM; Bass SA; Khurana Hershey GK
J Immunol; 2014 Feb; 192(3):859-66. PubMed ID: 24337738
[TBL] [Abstract][Full Text] [Related]
6. Protective role of Galectin-7 for skin barrier impairment in atopic dermatitis.
Umayahara T; Shimauchi T; Iwasaki M; Sakabe JI; Aoshima M; Nakazawa S; Yatagai T; Yamaguchi H; Phadungsaksawasdi P; Kurihara K; Tokura Y
Clin Exp Allergy; 2020 Aug; 50(8):922-931. PubMed ID: 32474952
[TBL] [Abstract][Full Text] [Related]
7. SERPINB3/B4 contributes to early inflammation and barrier dysfunction in an experimental murine model of atopic dermatitis.
Sivaprasad U; Kinker KG; Ericksen MB; Lindsey M; Gibson AM; Bass SA; Hershey NS; Deng J; Medvedovic M; Khurana Hershey GK
J Invest Dermatol; 2015 Jan; 135(1):160-169. PubMed ID: 25111616
[TBL] [Abstract][Full Text] [Related]
8. CXCR3 Requirement for the Interleukin-13-Mediated Up-Regulation of Interleukin-13Rα2 in Pulmonary Fibroblasts.
Barnes JC; Lumsden RV; Worrell J; Counihan IP; O'Beirne SL; Belperio JA; Fabre A; Donnelly SC; Boylan D; Kane R; Keane MP
Am J Respir Cell Mol Biol; 2015 Aug; 53(2):217-25. PubMed ID: 25514189
[TBL] [Abstract][Full Text] [Related]
9. The role of interleukin-17 in mouse models of atopic dermatitis and contact dermatitis.
Heo WI; Lee KE; Hong JY; Kim MN; Oh MS; Kim YS; Kim KW; Kim KE; Sohn MH
Clin Exp Dermatol; 2015 Aug; 40(6):665-71. PubMed ID: 25684357
[TBL] [Abstract][Full Text] [Related]
10. ILC2 activation by keratinocyte-derived IL-25 drives IL-13 production at sites of allergic skin inflammation.
Leyva-Castillo JM; Galand C; Mashiko S; Bissonnette R; McGurk A; Ziegler SF; Dong C; McKenzie ANJ; Sarfati M; Geha RS
J Allergy Clin Immunol; 2020 Jun; 145(6):1606-1614.e4. PubMed ID: 32179159
[TBL] [Abstract][Full Text] [Related]
11. Oleanolic acid acetate inhibits atopic dermatitis and allergic contact dermatitis in a murine model.
Choi JK; Oh HM; Lee S; Park JW; Khang D; Lee SW; Lee WS; Rho MC; Kim SH
Toxicol Appl Pharmacol; 2013 May; 269(1):72-80. PubMed ID: 23499868
[TBL] [Abstract][Full Text] [Related]
12. Injury, dysbiosis, and filaggrin deficiency drive skin inflammation through keratinocyte IL-1α release.
Archer NK; Jo JH; Lee SK; Kim D; Smith B; Ortines RV; Wang Y; Marchitto MC; Ravipati A; Cai SS; Dillen CA; Liu H; Miller RJ; Ashbaugh AG; Uppal AS; Oyoshi MK; Malhotra N; Hoff S; Garza LA; Kong HH; Segre JA; Geha RS; Miller LS
J Allergy Clin Immunol; 2019 Apr; 143(4):1426-1443.e6. PubMed ID: 30240702
[TBL] [Abstract][Full Text] [Related]
13. Keratinocytes activated by IL-4/IL-13 express IL-2Rγ with consequences on epidermal barrier function.
Progneaux A; Evrard C; De Glas V; Fontaine A; Dotreppe C; De Vuyst E; Nikkels AF; García-González V; Dumoutier L; Lambert de Rouvroit C; Poumay Y
Exp Dermatol; 2023 May; 32(5):660-670. PubMed ID: 36645024
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid induces interleukin-13 (IL-13) receptor alpha2 expression and inhibits IL-13 signaling in primary human bronchial epithelial cells.
Zhao Y; He D; Zhao J; Wang L; Leff AR; Spannhake EW; Georas S; Natarajan V
J Biol Chem; 2007 Apr; 282(14):10172-9. PubMed ID: 17287216
[TBL] [Abstract][Full Text] [Related]
15. Accelerated and progressive and lethal liver fibrosis in mice that lack interleukin (IL)-10, IL-12p40, and IL-13Rα2.
Mentink-Kane MM; Cheever AW; Wilson MS; Madala SK; Beers LM; Ramalingam TR; Wynn TA
Gastroenterology; 2011 Dec; 141(6):2200-9. PubMed ID: 21864478
[TBL] [Abstract][Full Text] [Related]
16. The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes.
Corrêa MP; Areias LL; Correia-Silva RD; D'Ávila SCGP; Leopoldino AM; Greco KV; Gil CD
Cells; 2021 Apr; 10(4):. PubMed ID: 33923930
[TBL] [Abstract][Full Text] [Related]
17. Association of polymorphisms in genes encoding IL-4, IL-13 and their receptors with atopic dermatitis in a Korean population.
Namkung JH; Lee JE; Kim E; Kim HJ; Seo EY; Jang HY; Shin ES; Cho EY; Yang JM
Exp Dermatol; 2011 Nov; 20(11):915-9. PubMed ID: 21913997
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E
Sawada Y; Honda T; Nakamizo S; Nakajima S; Nonomura Y; Otsuka A; Egawa G; Yoshimoto T; Nakamura M; Narumiya S; Kabashima K
J Allergy Clin Immunol; 2019 Nov; 144(5):1265-1273.e9. PubMed ID: 31301371
[TBL] [Abstract][Full Text] [Related]
19. IL-13 receptor alpha2 selectively inhibits IL-13-induced responses in the murine lung.
Zheng T; Liu W; Oh SY; Zhu Z; Hu B; Homer RJ; Cohn L; Grusby MJ; Elias JA
J Immunol; 2008 Jan; 180(1):522-9. PubMed ID: 18097054
[TBL] [Abstract][Full Text] [Related]
20. Induction of the IL-13 receptor alpha2-chain by IL-4 and IL-13 in human keratinocytes: involvement of STAT6, ERK and p38 MAPK pathways.
David M; Ford D; Bertoglio J; Maizel AL; Pierre J
Oncogene; 2001 Oct; 20(46):6660-8. PubMed ID: 11709700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
